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ChangePreviously institutionalized older patients with schizophrenia show changes in cognitive and functional ca-
pacity over time. This study examined changes in real-world functioning in a sample of people with schizo-
phrenia who varied in their history of long-term institutionalization and related changes in real world
functioning to changes in cognition and functional capacity over the follow-up period.
Older patients with schizophrenia (n = 111) were examined with assessments of cognitive functioning,
functional capacity, clinical symptoms, and everyday functioning. They were then followed up to 45 months
and examined up to two times. Mixed-model regression was used to examine changes in real-world func-
tioning in social, everyday living, and vocational domains over the follow-up period and identify potential
predictors of change.
Everyday functioning worsened over time in all three domains. Although length of longest hospitalization
predicted worsening, this inﬂuence was eliminated when the course of functional capacity was used to pre-
dict the course of everyday functioning. For both vocational and everyday living domains, as well as the com-
posite score on functional status, worsening in performance based measures of everyday functioning and
social competence predicted worsening in real world functioning. Changes in negative symptoms further
predicted worsening in the everyday living domain.
Worsening in everyday functioning is found in people with schizophrenia and those with a history of greater
chronicity and severity of illness seem more affected. These inﬂuences seem to be expressed through wors-
ening in the ability to perform everyday functional skills. Potential causes of these changes and implications
for reducing these impairments are discussed.
© 2014 Elsevier Inc. All rights reserved.1. Introduction
Schizophrenia is a highly debilitating illness and a chronic condition
that leads to disruptions in daily life functioning. Schizophrenia patients
demonstrate impairment in their everyday functioning, with deﬁcien-
cies in social, cognitive and real world activities that are detectable at
the time of the ﬁrst episode of illness. In recent years interest in the re-
lationship between cognitive and functional impairments in patients
with schizophrenia has grown (Green et al., 2000). Abundant evidence
suggests that cognitive deﬁcits are important determinants of impair-
ments in most functional domains and are targeted for treatment in
schizophrenia (Buchanan et al., 2005). Cognitive impairments haved Behavioral Sciences, Univer-
Street, Suite 1450, Miami, FL
y).
rights reserved.been shown to exert a general inﬂuence on functioning (Evans et al.,
2003), with minimal evidence of differential correlations with different
functional domains. Cognitive impairments are evident at the onset of
illness (Seidman et al., 2010), are stable over the lifetime for themajor-
ity of patients (Heaton et al., 2001), appear to worsen only in the
“oldest-old” patients (Loewenstein et al., in press) and can be affected
by treatments (Kurtz et al., 2009).
Real world disabilities may be directly inﬂuenced by deﬁcits in
functional capacity (Patterson et al., 2001a), measured by the ability
to perform everyday living skills, social activities and vocational abil-
ities (Harvey et al., 2007). Leifker et al. (2009) suggested that
performance-based measures of everyday functioning are more di-
rectly related to everyday functioning than NP test performance, al-
though other studies have found slightly different results (Heinrichs
et al., 2010). Severity of symptoms negatively impacts on everyday
functioning in the absence of major correlations with either NP test
performance or functional capacity (Bowie et al., 2008, 2010).
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tioning has a generally “normal” course of age-related decline and
that the decline among most schizophrenia patients is similar to
healthy populations. However, older patients with an extensive histo-
ry of illness and protracted institutionalization have shown a greater
progressive decline (Fucetola et al., 2000, Harvey et al., 1999). These
declines have also been observed among patients who are no longer
institutionalized (Harvey et al., 2010). Speciﬁcally, our recent work
indicated that formerly institutionalized patients demonstrated de-
cline in functional capacity over time compared to healthy controls
and patients who had never experienced a lengthy institutional
stay. We found that longer duration of lifetime hospitalization was as-
sociated with worsening on performance-based measures of social
and everyday living skills, suggesting the potential for worsening in
this subgroup of patients even if they are no longer institutionalized.
Further, risk factors previously identiﬁed as predictors of functional
decline, including educational attainment, exerted an adverse impact
on the course of functional capacity in our previous study.
In the present study, we examine the course of real world func-
tioning in the same sample of older patients with schizophrenia
who were examined in our previous report. The present analysis is
unique for several reasons. First, there has never been a short-term
longitudinal study of older patients that was oriented toward decline
in everyday functioning. This study examines the same sample of pa-
tients wherein a subset worsened in their functional capacity in the
previous follow-up analyses. Second, we are able to examine the lon-
gitudinal inﬂuence of previously identiﬁed cross-sectional predictors
of impairments in everyday functioning in three functional domains:
social, community activities, and vocational functioning (Bowie et al.,
2008, 2010). These predictors include cognitive functioning, function-
al capacity, and social skills. In addition, we use the previously identi-
ﬁed longitudinal predictors of decline in functional capacity (length
of institutional stay, education) to predict the longitudinal course of
real-world outcomes in these same three domains. Finally, we pro-
spectively examine the inﬂuence of symptoms that had previously
been reported to inﬂuence everyday functioning (i.e., depression
and negative symptoms) on a cross-sectional basis. We examine the
course of the three domains of everyday functioning, as well as a
composite score based on all three domains, and used the variables
described above to predict the course of everyday functioning in
these three domains.
2. Methods
2.1. Participants
We previously reported on the collection and assessment of our
schizophrenia sample in several cross-sectional reports and one longi-
tudinal analysis (Bowie et al., 2008, Harvey et al., 2010, Leifker et al.,
2009). Older community dwelling outpatients whomet DSM-IV criteria
for schizophrenia or schizoaffective disorderwere enrolled in this longi-
tudinal study investigating the course of cognitive and functional status.
Exclusion criteria consisted of a primary DSM-IV Axis I diagnosis other
than schizophrenia or schizoaffective disorder, a lifetime history of
past substance dependence or current substance abuse disorders,
Mini-Mental State Examination (MMSE) (Folstein et al., 1975) score
below 18, Wide Range Achievement Test 3rd Edition (WRAT-3)
(Jastak and Wilkinson, 1994) reading grade-equivalent of grade 6 or
less, or any medical illnesses that might interfere with the assessment
of cognitive functioning. The Comprehensive Assessment of Symptoms
and History (CASH) (Andreasen et al., 1992) was completed by trained
research assistants and diagnosis was conﬁrmed by a senior clinician.
Subjects were also required to demonstrate continued illness at the
time of recruitment, as evidenced by meeting at least one of three
criteria: 1) an inpatient admission for psychosis in the past two years;
2) an emergency room visit for psychosis in the past two years; or 3)a score on the PANSS positive symptoms items delusions, hallucina-
tions, or conceptual disorganization of 4 (moderate) or more at the
time of their baseline assessment. The reason for this criterion was to
ensure that patients had not fully recovered from their illness. Outpa-
tient status was deﬁned as living outside of any institutional setting, in-
cluding a nursing home while not excluding a group home setting.
In this patient group, all subjects were receiving treatment with
second-generation antipsychotic medications at the time of the as-
sessment. Recruitment was conducted at a VA or State Hospital or ac-
ademic medical center and each subject received $50 for their
participation at each assessment. After the testing procedures were
fully explained, all subjects signed a written informed consent form
approved by the institutional review board at each research site,
where ethical approval was obtained. Healthy controls were included
in the overall project, but are not included in these analyses because
they did not have case managers to rate their everyday functioning.
2.2. Measures
All subjects completed the test battery in a ﬁxed order. All inter-
viewers received extensive training in performing all assessments
and every three months their performance was evaluated through
re-rating of training tapes, dual-ratings of the functional status mea-
sures with a senior clinical psychologist, and quality assurance assess-
ments of all testing.
2.2.1. Performance-based Measures of Functional Capacity
The UCSD Performance-Based Skills Assessment Battery (UPSA)
(Patterson et al., 2001a) was designed to directly evaluate the ability
to perform everyday tasks that are considered necessary for indepen-
dent functioning in the community. This test uses standardized role-
playing situations to evaluate skills in different functional domains.
In this study, four derived domains of the UPSA were used: Compre-
hension/Planning (e.g., organizing outings to the beach or the zoon),
Finance (e.g., counting change, and paying bills), Transportation
(e.g., using public transportation), and Communication (e.g., using
the telephone, rescheduling medication appointments). We excluded
the household chores subtest because the analogue kitchen required
was not portable enough to be used at ﬁeld sites. We then re-
standardized the scores to a 100-point scale, like the original 5-
subtest UPSA, thus allowing comparisons to previous results. This
modiﬁed version was used in our previous reports with the UPSA
(Bowie et al., 2008, Harvey et al., 2010).
The Social Skills Performance Assessment (SSPA) (Patterson et al.,
2001b) is a social role-play task in which the subject initiates and
maintains a conversation in two 3-minute role-play tasks: greeting
a new neighbor and calling a landlord to request a repair for a leak
that has gone unﬁxed. These sessions were audiotaped and scored
by a trained rater who was unaware of diagnosis (patient or HC as
part of a larger study) and all other data. Dimensions of social skills
scored include ﬂuency, clarity, focus, negotiation ability, persistence,
and social appropriateness. These raters were trained to the gold
standard ratings of the instrument developers, with an Intraclass Cor-
relation Coefﬁcient (ICC) of .86 and high inter-rater reliability was
maintained at three months (ICC = .87). The mean of the ratings on
these variables across the two measures was used in this study.
2.2.2. Cognitive Assessment
Neuropsychological tests were selected to represent diverse cogni-
tive domains that were previously shown to be the most consistently
correlated with functional skills (Green et al., 2000, Harvey et al.,
2004). These tests included the Trail Making Test Parts A and B
(Reitan and Wolfson, 1993), learning trials 1–5, from the Rey Auditory
Learning Test (RAVLT) (Spreen and Strauss, 1998), FAS verbal ﬂuency
(Spreen and Strauss, 1998), animal naming (Spreen and Strauss,
1998), The Wisconsin Card Sorting Test-64 card version (Heaton et al.,
Table 1
Demographic and baseline performance and clinical characteristics.
Demographic characteristics
N 111
% Male 73
Ethnicity (%)
Caucasian 58
African-American 33
Other 9
M SD
Age 56.99 9.00
Years of education 11.86 4.42
UPSA scaled score 72.19 17.38
SSPA mean score 3.89 0.74
Cognitive composite score −1.47 0.95
Illness history variables
M SD Min Max Median
Longest hospital stay (months) 16.12 28.61 1 360 6
Number of hospitalizations 7.72 6.95 1 36 5
Total lifetime months in hospital 43.62 61.40 1 366 20
Age at ﬁrst admission 23.65 10.26 16 45 23
Baseline illness severity variables
PANSS negative symptoms 2.05 0.82 Reported as mean
item score
PANSS positive symptoms 1.86 0.83 Reported as mean
item score
BDI depression 10.69 9.91
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bol Coding subtests of theWechsler Adult Intelligence Scale, 3rd edition
(WAIS-III) (Wechsler, 1997)were also included. This batterywas devel-
oped prior to the ﬁnalization of the MATRICS consensus cognitive bat-
tery (Neuchterlein et al., 2008), but covers similar cognitive domains.
Normatively corrected t-scores were created from published norms as
we previously described.
2.2.3. Symptom Assessment
Severity of schizophrenia symptoms was assessed using the Posi-
tive and Negative Syndrome Scale (PANSS) (Kay, 1991). This is a
30-item scale with seven items measuring positive symptoms,
seven items measuring negative symptoms, and sixteen items mea-
suring general aspects of psychopathology and is completed after a
structured interview. Each item is scored on a scale ranging from 1
(absent) to 7 (extreme), with item ratings incorporating the behav-
ioral effects of symptoms as well as their severity. Raters were trained
to adequate reliability with ICCs from .86 to .92. We used theWhite et
al. (White et al., 1997a) factor analysis derived scores for negative
symptoms on the PANSS, in line with our previous studies. Patients
reported their depression severity on the Beck Depression
Inventory-Second edition (BDI-II) (Beck et al., 1996).
2.2.3.1. Assessment of everyday functioning. In order to examine real-
world functional performance, the Speciﬁc Levels of Function Scale
(SLOF) (Schneider and Streuening, 1983) was employed. This scale
is a 43-item caretaker report of a patient’s behavior and functioning
across the following domains: Interpersonal Relationships (e.g., initi-
ating, accepting and maintaining social contacts; effectively commu-
nicating), Activities (e.g., shopping, using telephone, paying bills,
use of leisure time, use of public transportation), and Work Skills
(e.g., employable skills, level of supervision, punctuality). In order to
obtain these ratings, a corroborated informant report method was
used. With the patient’s permission, a caseworker for the patient
was directly interviewed in order to obtain information on real-
world performance. All informants indicated that they knew the
patient “very well” on the SLOF’s 5-point Likert scale. The scale
has excellent interrater reliability, factorial validity, and internal
consistency (Leifker et al., 2011). There are three other subscales
on the SLOF that were not administered because they either
assessed aspects of function that are not associated with chronic
mental illness (Physical functioning and Personal care) or because
they measure disruptive behaviors (Social acceptability). We used
the three subscales and a composite generated from total scores
on these three scales as our everyday functioning measures.
2.3. Procedures
2.3.1. Assessment and Follow-up
This project was approved by all applicable local IRBs and all par-
ticipants provided signed informed consent for all initial and subse-
quent follow-up assessments, which were scheduled at 18 month
intervals after initial entry into the study. Patients were examined
with the same assessments in the same sequence at each subsequent
follow-up visit (with the exception of the MMSE and WRAT Recogni-
tion). Alternate test forms were not available for most of the tests, so
the same forms were used for all assessments for all participants.
Telephone calls and mail contact were used to stay in touch with par-
ticipants between assessments.
2.3.2. Determination of Institutionalization Status
Length of longest single hospital stay in months was a critical var-
iable in the analyses of institutionalization status. This information
was collected from medical records only, because of concerns with
the accuracy of self report on the part of patients, using the sameprocedure as our previous report. Some data were not available be-
cause of missing information as described before (Harvey et al.,
2010).
2.4. Data Analyses
A mixed-effects model repeated-measures (MMRM) (Gibbons,
2000) was used for the main set of analyses which examined the ef-
fect of individual differences variables: longest hospitalization, sex,
age, and education on the course of everyday functioning. We then
repeated these analyses including the dynamic performance-based
covariates, including composite NP test performance, the UPSA, and
the SSPA. In ﬁnal set of analyses, we added the symptom variables
that had been shown to have a cross-sectional relationship with ev-
eryday functioning, including PANSS negative symptoms and self-
reported depression, also entered as dynamic covariates.
To complement the main analysis and to determine if changes in
everyday functioning are evident across ages, or restricted to aging
population, a Generalized Linear Mixed-Model (GLMM) regression
was used. GLMM technique maximizes the use of the longitudinal na-
ture of the data as it permits the inclusion of single as well as multiple
measurements per person, and irregular intervals between measure-
ments. The effect of interest was age (time). Splines were used to
model age effects (i.e., time) on SLOF score. A spline model estimates
the response relation without assuming that the data follow a partic-
ular form, such as linear or cubic. This allows for an evaluation of the
functional form of associations. Analyses were carried using SAS soft-
ware version 9.3 (Cary, NC, USA).
3. Results
111 patients were assessed at baseline. 102 were assessed twice,
and 57 were assessed three times. The average time interval between
ﬁrst to second assessment was 1.5 years (SD = 0.57). Average time
to third assessment was 1.75 years (SD = 0.58). Table 1 presents
the baseline scores on the demographic variables and the
performance-based predictor variables. Table 2 presents the observed
case scores on the performance-based predictors.
Table 2
Functional Capacity, Neuropsychological Performance, and Everyday Functioning over
the follow-up period.
First follow-up (N = 104)
M SD
UPSA 74.60 18.25
3.92 0.74
−1.52 0.90
Second follow-up (N = 57)
M SD
UPSA 73.18 18.27
SSPA 3.82 0.75
NP performance −1.60 0.92
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and three SLOF subscales. Our ﬁrst analysis focused on demographic
predictors of change over time in SLOF total score, evaluating the
time effects and also predicting the change in SLOF scores using the
unchanging covariates age, education, and longest psychiatric hospi-
talization. In the ﬁrst model, we examined the effects of time, age,
sex, education, and longest hospital stay on SLOF total score to deter-
mine if there were signiﬁcant overall effects. For SLOF total score, the
overall model was statistically signiﬁcant [X2(3) = 60.31, p b .001].
There were statistically signiﬁcant effects of time [X2(1) = 8.01,
p b .003], age, [X2(1) = 59.41, p b .001], and longest institutional
stay [X2(1) = 5.64, p b .05]. Sex and education were not statistically
signiﬁcantly associated with SLOF scores.
Next, performance-based measures (UPSA, SSPA, NP performance)
were added to themodel. The overall model was statistically signiﬁcant
[X2(7) = 105.74, p b .001]. Therewere statistically signiﬁcant effects of
time [X2(1) = 7.67, p b .005], and age[X2(1) = 20.16, p b .001]. There
were also statistically signiﬁcant effect of change in UPSA scores
[X2(1) = 12.85, p b 0.001], and SSPA scores [X2(1) = 5.26, p b 0.05].
For bothworsening in performance on the functional capacitymeasures
was associated with worsening in total estimates of real-world func-
tioning. NP performance was not associated with SLOF scores, and in
the extendedmodel the effect of longest institutional staywas no longer
statistically signiﬁcant [X2(1) = 2.35, p = .125].Baseline First Followup Second Followup
105
SLOF total
Vocational
100
95
90
85
80
24.5
23.5
22.5
21.5
20.5
19.5
24
23
22
21
20
Baseline First Followup Second Followup
* p<.05
* p<.05
SLOF Vocational Scores Over Three
Assessments
SLOF Total Scores Over Three
Assessments
Fig. 1. Everyday functioning oNext we repeated the analysis for each of the three SLOF everyday
functioning subscales (i.e. social, everyday activities, and vocational).
For social functioning, the overall model was statistically signiﬁcant
[X2(3) = 19.18, p b 0.01]. However, only time had a signiﬁcant associ-
ation [X2(1) = 7.28, p b .007]. For everyday activities, the overall
model was signiﬁcant[X2(6) = 157.96, p b .001]. There were signiﬁ-
cant effects of time [X2(1) = 4.64, p b .05], and age [X2(1) = 43.05,
p b .001], but education, sex, and longest hospitalization were not sig-
niﬁcant predictors. Declines in UPSA scores [X2(1) = 24.01, p b .001],
and SSPA scores[X2(1) = 4.83, p = .03], were signiﬁcant predictors
of worsening of SLOF everyday functioning, but changes in NP test per-
formance did not. Finally, for vocational functioning, the overall model
was signiﬁcant [X2(6) = 83.06, p b .001]. The effect of time of assess-
ment was signiﬁcant [X2(1) = 8.11, p = .004], as was the effect of
age [X2(1) = 16.80, p b .001]. Worsening UPSA scores [X2(1) = 6.51,
p b .025], and SSPA scores [X2(1) = 4.60, p = .04] were signiﬁcant
predictors of worsening in vocational functioning, but NP test perfor-
mance again did not predict changes over time.
We next examined if symptoms were signiﬁcant predictors
of course of everyday functioning. Results remained
unchanged after adding symptom severity to the models de-
scribed above. Change in negative symptoms predicted the
course of everyday activities [X2 (1) = 5.35, p b .05]. No other asso-
ciations between symptoms and everyday functioning were statisti-
cally signiﬁcant.
Fig. 2 presents the SLOF composite measure as a function of the
age of the participants. As the ﬁgure demonstrates, everyday func-
tioning continuously deteriorates across adult life [F(2,139) =
22.15, p b 0.0001]. Although visual inspection of Fig. 2 suggested
that the functional deterioration may accelerate after age 55, this
was not supported by a formal statistical test [F test for non-linear
trend (1,139) = 1.61, p = 0.20], but sample size in the older ages
may limit statistical power.
4. Discussion
There are several ﬁndings of potential interest in this study. First,
older people with schizophrenia show modest worsening in their ev-
eryday functioning as a group and these changes are predicted bySLOF Everyday Functioning Scores 
Over Three Assessments
40
41
42
43
44
45
46
47
48
49
50
Baseline First Followup Second Followup
Everyday Functioning
* p<.05
Interpersonal Functioning
31
30
29
28
27
26
25
24
Baseline First Followup Second Followup
* p<.05
SLOF Interpersonal Functioning Scores
Over Three Assessments
ver the follow-up period.
Fig. 2. Age-associated changes in everyday functioning. Gray dots represent Individual participants. Black line represents the average SLOF score per age as modelled using spline;
Dotted black line represents the 95% conﬁdence intervals.
e51A. Reichenberg et al. / Schizophrenia Research: Cognition 1 (2014) e47–e52several of the variables that we measured. Importantly, we expand on
our previous ﬁndings that history of longer institutional stay predicts
worsening in performance-based measures of functional abilities by
showing that history of institutionalization predicts worsening in real-
world functioning as well. The results also include a demonstration
that worsening in performance on measures of social skills and func-
tional capacity predicts worsening of everyday functioning in two of
the three everyday functional domains that we measured. Further,
these data also suggest that longer institutionalization inﬂuences wors-
ening in real-world functioning by leading to deterioration in functional
skills. Worsening in negative symptomswas also associatedwith wors-
ening in everyday activities, while the previous observed cross-
sectional inﬂuence of depression on everyday functioning did not hold
up in a longitudinal study.
Limitations of this study should be acknowledged. Follow up as-
sessments did not occur for every patient, but we previously
(Harvey et al., 2010) found no difference in any of the current predic-
tor variables across patients who were and were not followed up.
Other factors, including medical illness, were not measured sufﬁ-
ciently to be used as predictor variables. This will be an important
topic for future research. Patients’ symptom severity was not substan-
tial leading to reduced ability to predict changes based on symptom-
atic worsening. Some of our previous cross-sectional ﬁndings
including the correlation of depression with everyday activities and
social amotivation as a predictor of social dysfunction, were challeng-
ing to evaluate in a sample with only minimal symptom dynamics.
We argue that this does not suggest that these factors are reduced
in their potential importance, but rather that we could not prove
that they produce functional decline.
The present sample is a unique one and there are few current pa-
tients who will experience extended institutional stays like some of
the members of the current sample experienced. However, the histor-
ical reasons for extended institutional stays, including treatment re-
sistance and aggressive behavior (White et al., 1997b), have not
been resolved as clinical issues. Later research should determine
whether treatment resistance, which is associated with longitudinal
ventricular enlargement (Davis et al., 1998), is the operative factor
in the functional declines seen and whether patients with persistently
severe psychotic symptoms evidence functional decline as previous
data has suggested (Harvey et al., 2003).When functional worsening is detected, it would be important to
at least speculate about the potential causes. This is a unique and
rarely studied population, with minimal longitudinal data available
on truly older patients. As a result, we have three hypotheses based
on our own research with patients who are similar to the current
population. The ﬁrst is that chronic psychosis associated with long-
term institutional stay exerts a neurotoxic effect. Multiple relapses
early in the illness have been shown to lead to cortical gray matter
loss (Cahn et al., 2006), consistent with the ﬁndings that persistent
psychosis leads to ventricular enlargement in chronic patients
(Davis et al., 1998). There are neurodegenerative possibilities as
well. We (Rapp et al., 2011) reported that in postmortem brain spec-
imens from people with schizophrenia, evaluated during life, the
numbers of amyloid plaques and neuroﬁbrillary tangles predicted
the level of cognitive impairments at the last assessment during life.
These patients were selected for not meeting neuropathological
criteria for Alzheimer’s disease, suggesting that normal range neuro-
degenerative changes may induce greater cognitive deﬁcit in people
with lifelong cortical challenge.
A third possibility arises from the domain of alterations in brain
structure. We (Friedman et al., 2008) have shown that chronic pa-
tients show evidence of reduced organization of white matter as
indexed by reduced levels of regional fractional anisoptropy in chron-
ic patients compared to ﬁrst episode patients. While these data are
cross-sectional, they suggest possible longitudinal changes in brain
structure. Thus, progressive changes in both the volume and structure
of the brain, involving white and gray matter, have been detected and
might be a possible mechanism that underlies the current ﬁndings.5. Conclusions
Worsening in everyday functioning is found in people with schizo-
phrenia and those with a history of greater chronicity and severity of
illness seem more affected. Direct interventions on functional capaci-
ty and underlying cognitive impairments are plausible treatment tar-
gets. Cognitive remediation interventions improve cognition and
functioning (Wykes et al., 2011) and work even in very poor outcome
patients 0). Reduction of risk factors for cortical deterioration might
provide a complementary approach.
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